The role of sphingosine-1 phosphate and ceramide-1 phosphate in trafficking of normal stem cells and cancer cells
暂无分享,去创建一个
M. Ratajczak | G. Schneider | J. Ratajczak | M. Suszyńska | S. Borkowska | Sylwia Borkowska | Gabriela Schneider
[1] B. Brüne,et al. Apoptotic cells enhance sphingosine‐1‐phosphate receptor 1 dependent macrophage migration , 2013, European journal of immunology.
[2] Junlin Qi,et al. Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice , 2013, Skeletal Muscle.
[3] L. Bendall,et al. Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells , 2013, Current opinion in hematology.
[4] M. Ratajczak,et al. An emerging link in stem cell mobilization between activation of the complement cascade and the chemotactic gradient of sphingosine-1-phosphate. , 2013, Prostaglandins & other lipid mediators.
[5] L. Malinina,et al. Nonvesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids , 2013, Nature.
[6] R. Stevens,et al. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. , 2013, Annual review of biochemistry.
[7] A. Gomez-Muñoz,et al. Ceramide 1-phosphate induces macrophage chemoattractant protein-1 release: involvement in ceramide 1-phosphate-stimulated cell migration. , 2013, American journal of physiology. Endocrinology and metabolism.
[8] A. Gomez-Muñoz,et al. New insights on the role of ceramide 1-phosphate in inflammation. , 2013, Biochimica et biophysica acta.
[9] M. Ratajczak,et al. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. , 2013, Stem cells and development.
[10] P. Houghton,et al. Bioactive Lipids S1P and C1P Are Prometastatic Factors in Human Rhabdomyosarcoma, and Their Tissue Levels Increase in Response to Radio/Chemotherapy , 2013, Molecular Cancer Research.
[11] M. Ratajczak,et al. Ceramide‐1‐Phosphate Regulates Migration of Multipotent Stromal Cells and Endothelial Progenitor Cells—Implications for Tissue Regeneration , 2013, Stem cells.
[12] M. Ratajczak,et al. Innate Immunity Derived Factors as External Modulators of the CXCL12 - CXCR4 Axis and Their Role in Stem Cell Homing and Mobilization , 2013, Theranostics.
[13] S. Khosla,et al. Sphingosine 1-Phosphate (S1P) Receptors 1 and 2 Coordinately Induce Mesenchymal Cell Migration through S1P Activation of Complementary Kinase Pathways* , 2013, The Journal of Biological Chemistry.
[14] Jaesik Park,et al. FTY720 preserved islet β‐cell mass by inhibiting apoptosis and increasing survival of β‐cells in db/db mice , 2013, Diabetes/metabolism research and reviews.
[15] M. Ratajczak,et al. Novel Evidence That Hematopoietic Stem/Progenitor Cells (HSPCs) Are Mobilized During Hemolysis in an Erythrocyte Lysis-Derived, Sphingosine-1-Phosphate (S1P)-Dependent manner—the Crucial Involvement of Complement Cascade (CC) Activation and Attenuation of CXCR4 Retention Signaling , 2012 .
[16] T. Hla,et al. Fine-tuning S1P therapeutics. , 2012, Chemistry & biology.
[17] N. Baldini,et al. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy , 2012, Front. Physio..
[18] J. Maciejewski,et al. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate grad , 2012, Leukemia.
[19] M. Ratajczak,et al. S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. , 2012, Blood.
[20] A. Gomez-Muñoz,et al. Ceramide 1-phosphate stimulates proliferation of C2C12 myoblasts , 2012, Biochimie.
[21] P. Gonzalez-Cabrera,et al. S1P1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis , 2012, Molecular Pharmacology.
[22] Xianghuo He,et al. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[23] J. Dipersio,et al. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. , 2012, Blood.
[24] R. Charnigo,et al. Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions , 2011, Clinical science.
[25] A. Moon,et al. Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3–Gαq coupling , 2011, Journal of Cell Science.
[26] M. Ratajczak,et al. CONDITIONING FOR HEMATOPOIETIC TRANSPLANTATION ACTIVATES THE COMPLEMENT CASCADE AND INDUCES A PROTEOLYTIC ENVIRONMENT IN BONE MARROW – A NOVEL ROLE FOR BIOACTIVE LIPIDS AND SOLUBLE C5b-C9 AS HOMING FACTORS , 2011, Leukemia.
[27] M. Ratajczak. The emerging role of microvesicles in cellular therapies for organ/tissue regeneration. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[28] Dong-Myung Shin,et al. The role of pluripotent embryonic-like stem cells residing in adult tissues in regeneration and longevity. , 2011, Differentiation; research in biological diversity.
[29] A. Borowsky,et al. S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. , 2011, American journal of physiology. Heart and circulatory physiology.
[30] D. Link,et al. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization , 2011, Leukemia.
[31] M. Lee,et al. To stay or to leave: Stem cells and progenitor cells navigating the S1P gradient. , 2011, World journal of biological chemistry.
[32] M. Tendera,et al. Circulating Very Small Embryonic-Like Stem Cells in Cardiovascular Disease , 2010, Journal of cardiovascular translational research.
[33] M. Ishii,et al. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo , 2010, The Journal of experimental medicine.
[34] A. Bielawska,et al. Blood sphingolipidomics in healthy humans: impact of sample collection methodology , 2010, Journal of Lipid Research.
[35] Caiying Guo,et al. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics , 2010, The Journal of experimental medicine.
[36] H. Fyrst,et al. An update on sphingosine-1-phosphate and other sphingolipid mediators. , 2010, Nature chemical biology.
[37] S. Pyne,et al. Sphingosine 1-phosphate and cancer , 2010, Nature Reviews Cancer.
[38] J. Saba,et al. S1P metabolism in cancer and other pathological conditions. , 2010, Biochimie.
[39] F. Thol,et al. Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1‐phosphate , 2010, Journal of cellular biochemistry.
[40] M. Ratajczak,et al. PLASMA SPHINGOSINE 1-PHOSPHATE IS A MAJOR CHEMOATTRACTANT THAT DIRECTS EGRESS OF HEMATOPOIETIC STEM PROGENITOR CELLS FROM BONE MARROW AND ITS LEVEL IN PERIPHERAL BLOOD INCREASES DURING MOBILIZATION DUE TO ACTIVATION OF COMPLEMENT CASCADE/MEMBRANE ATTACK COMPLEX , 2010, Leukemia.
[41] Ludwig Kappos,et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. , 2010, The New England journal of medicine.
[42] M. Hiraiwa,et al. Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies1 , 2009, Journal of Lipid Research.
[43] G. Camussi,et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats , 2009, Journal of cellular and molecular medicine.
[44] T. Blom,et al. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2. , 2009, Endocrinology.
[45] F. Bornancin,et al. Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro. , 2009, Microvascular research.
[46] T. Hla,et al. S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. , 2009, Cancer letters.
[47] D. Brindley,et al. Lipid phosphate phosphatases and signaling The work was supported by the Canadian Institutes of Health Research. Published, JLR Papers in Press, December 9, 2008. , 2009, Journal of Lipid Research.
[48] A. Gomez-Muñoz,et al. Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor. , 2009, Cellular signalling.
[49] T. Ohmori,et al. Antagonism of Sphingosine 1-Phosphate Receptor-2 Enhances Migration of Neural Progenitor Cells Toward an Area of Brain Infarction , 2008, Stroke.
[50] R. Proia,et al. The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.
[51] T. Hla,et al. The vascular S1P gradient-cellular sources and biological significance. , 2008, Biochimica et biophysica acta.
[52] Yong Song Gho,et al. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. , 2008, Blood.
[53] B. Kinzel,et al. Wild-type levels of ceramide and ceramide-1-phosphate in the retina of ceramide kinase-like-deficient mice. , 2008, Biochemical and biophysical research communications.
[54] M. Gladwin,et al. Chronic Hyper-Hemolysis in Sickle Cell Anemia: Association of Vascular Complications and Mortality with Less Frequent Vasoocclusive Pain , 2008, PloS one.
[55] H. Bonkovsky,et al. Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate , 2008, Circulation research.
[56] P. V. Van Veldhoven,et al. Neutropenia with Impaired Immune Response to Streptococcus pneumoniae in Ceramide Kinase-Deficient Mice , 2008, The Journal of Immunology.
[57] Yusuf A. Hannun,et al. Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.
[58] Yannick Jacques,et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor , 2007, Nature Immunology.
[59] Ulrich H. von Andrian,et al. Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral Tissues , 2007, Cell.
[60] V. Brinkmann. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. , 2007, Pharmacology & therapeutics.
[61] J. Cyster,et al. Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.
[62] P. Zoltick,et al. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. , 2006, Blood.
[63] J Ratajczak,et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.
[64] Yiling Lu,et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. , 2006, Cancer cell.
[65] Alejandro Erices,et al. Mesenchymal Stem Cells and the Treatment of Cardiac Disease , 2005 .
[66] R. Proia,et al. Essential Role for Sphingosine Kinases in Neural and Vascular Development , 2005, Molecular and Cellular Biology.
[67] C. Chalfant,et al. Ceramide-1-phosphate: the "missing" link in eicosanoid biosynthesis and inflammation. , 2005, Molecular interventions.
[68] K. Chiba. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. , 2005, Pharmacology & therapeutics.
[69] S. Spiegel,et al. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling , 2005, Journal of Cell Science.
[70] S. Pyne,et al. Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. , 2005, The Biochemical journal.
[71] Ying Xu,et al. Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients , 2005, Science.
[72] T. Hla. Dietary Factors and Immunological Consequences , 2005, Science.
[73] R. Förster,et al. Sphingosine-1-Phosphate Mediates Migration of Mature Dendritic Cells1 , 2005, The Journal of Immunology.
[74] D. Zaller,et al. Sphingosine 1‐phosphate receptor agonist FTY720‐phosphate causes marginal zone B cell displacement , 2005, Journal of leukocyte biology.
[75] A. Parrill,et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. , 2005, Chemistry & biology.
[76] G. Seitz,et al. The Role of Sphingosine 1‐Phosphate Receptors in the Trafficking of Hematopoietic Progenitor Cells , 2005, Annals of the New York Academy of Sciences.
[77] F. Bernardi,et al. Circadian Rhythms in Mouse Blood Coagulation , 2005, Journal of biological rhythms.
[78] Michael D. Davis,et al. Sphingosine 1-Phosphate Analogs as Receptor Antagonists* , 2005, Journal of Biological Chemistry.
[79] R. Proia,et al. The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic Angiogenesis* , 2004, Journal of Biological Chemistry.
[80] J. Cyster,et al. FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[81] G. Seitz,et al. The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells. , 2004, Blood.
[82] P. Houghton,et al. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. , 2003, Cancer research.
[83] Naftali Kaminski,et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[84] M. Tanimoto,et al. Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization , 2003, Bone Marrow Transplantation.
[85] R. Discipio,et al. Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells1 , 2002, The Journal of Immunology.
[86] James R. Van Brocklyn,et al. Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase β , 2002 .
[87] J. Chun,et al. Marked Perinatal Lethality and Cellular Signaling Deficits in Mice Null for the Two Sphingosine 1-Phosphate (S1P) Receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3* , 2002, The Journal of Biological Chemistry.
[88] R. Taichman,et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 , 2002, Nature Immunology.
[89] A. Morris,et al. Roles for lipid phosphate phosphatases in regulation of cellular signaling. , 2002, Biochimica et biophysica acta.
[90] B. Friedman,et al. Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3* , 2001, The Journal of Biological Chemistry.
[91] J. P. Hobson,et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.
[92] Y. Yanagawa,et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L‐positive T cells in Peyer’s patches by FTY720‐induced lymphocyte homing , 1998, Immunology.
[93] D. Brindley,et al. Mammalian Lipid Phosphate Phosphohydrolases* , 1998, The Journal of Biological Chemistry.
[94] H. Kataoka,et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. , 1998, Journal of immunology.
[95] Y. Igarashi,et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. , 1997, Journal of biochemistry.
[96] T. Springer,et al. The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood , 1997, The Journal of experimental medicine.
[97] A. Gomez-Muñoz,et al. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides. , 1995, Molecular pharmacology.
[98] M. Pallansch,et al. Circadian and circannual aspects of the complement cascade - new and old results, differing in specificity. , 1980, Chronobiologia.
[99] C. McCall,et al. The effect of cobra venom factor (CVF) activation of the complement cascade on leukocyte circadian variation in the rat , 1977, Experientia.
[100] M. Ratajczak,et al. A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients , 2012, Leukemia.
[101] T. Hla,et al. Sphingosine 1-phosphate in coagulation and inflammation , 2011, Seminars in Immunopathology.
[102] G. Francis,et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis , 2010, Nature Reviews Drug Discovery.
[103] H. Nagawa,et al. Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation. , 2006, The Journal of surgical research.
[104] H. Nagawa,et al. Sphingosine 1-Phosphate Receptor Expression Profile in Human Gastric Cancer Cells: Differential Regulation on the Migration and Proliferation1 , 2006 .
[105] T. Prior,et al. Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. , 2002, Cancer letters.